featured
Incidence and Risk of Tumor Lysis Syndrome in Patients With Relapsed CLL Treated With Venetoclax
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Incidence and Risk of Tumor Lysis Syndrome in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) Treated With Venetoclax in Routine Clinical Practice
Leukemia and Lymphoma 2020 May 25;[EPub Ahead of Print], AB Koehler, N Leung, TG Call, KG Rabe, SJ Achenbach, W Ding, SS Kenderian, JF Leis, Y Wang, E Muchtar, SR Hayman, PJ Hampel, HD Finnes, SM Schwager, SL Slager, NE Kay, SA ParikhFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.